The latest technical development in the field of positron emission tomography/computed tomography (PET/CT) imaging has been the extension of the PET axial field-of-view. As a result of the increased number of detectors, the long axial field-of-view (LAFOV) PET systems are not only characterized by a larger anatomical coverage but also by a substantially improved sensitivity, compared with conventional short axial field-of-view PET systems. In clinical practice, this innovation has led to the following optimization: (1) improved overall image quality, (2) decreased duration of PET examinations, (3) decreased amount of radioactivity administered to the patient, or (4) a combination of any of the above. In this review, novel applications of LAFOV PET in oncology are highlighted and future directions are discussed.
1 March 2026 in IEEE Transactions on Radiation and Plasma Medical Sciences
Simultaneous dual-tracer positron emission tomography (PET) allows for the measurement of two distinct physiological processes within a single scan, i.e. under identical biological conditions. Quantification of 89Zr-labeled monoclonal antibody (89ZrmAb) uptake can be influenced by perfusion. Perfusion can be measured using 15.OH2O PET, but considerable variability in perfusion between scans may be an issue, there is a need to measure it at the same time as 89ZrmAb uptake. Based on the high sensitivity of long axial field-of-view (LAFOV) PET, this simulation study uses digital twins based on real patient scans to evaluate the feasibility of 15OH2O and 89ZrmAb dual-tracer imaging. Using a 15-minute scanning protocol, kinetic-based and subtraction-based methods were employed to recover 15OH2O kinetic parameters (K1 and VT) at both volume-of-interest (VOI) and voxel levels for various tracer uptake scenarios. Quantitative assessment was carried out using scatter and Bland-Altman plots by comparing 15OH2O parameters derived from a dual-tracer scan with those derived from the corresponding single tracer 15OH2O results. Both methods showed excellent recovery of 15OH2O kinetic parameters, with correlation coefficients exceeding 0.99 for VOI-level estimates and 0.94 for voxel-level estimates. Performance was further validated through bias versus standard deviation analyses. This study demonstrates the feasibility of a clinically practical 15-minute protocol for a simultaneous 15OH2O and 89ZrmAb PET acquisition while retaining accuracy of 15OH2O quantification.
The advent of long-axial-field-of-view (LAFOV) PET/CT systems has significantly improved whole-body imaging by providing higher sensitivity and extended torso coverage. However, PET/CT potential misalignment remains a challenge, potentially introducing artifacts and quantification errors. Moreover, PET protocols with reduced scanning duration and dose, as well as the use of ultra-low-dose CT (ULD-CT), are increasingly relevant in clinical practice and research. This study aimed to evaluate the robustness and generalizability of a deep-learning coregistration framework for PET/CT alignment using low-dose PET and ULD-CT across various tracers with a LAFOV system. Methods: In total, 63 scans with 4 different tracers (89Zr-trastuzumab, 15O-H2O, 18F-MC225, and 18F-FDG) were included to assess PET and CT alignment improvements. Further evaluation was performed by comparing CT scans coregistered to the original PET images (rCT) with those coregistered to low-count (50%, 25%, and 12.5% of original counts) PET images (LC-rCT). Dice similarity coefficient, Jaccard similarity coefficient, Hausdorff distance, and average surface distance were used as evaluation metrics. Furthermore, ULD-CT coregistered to PET (rULD-CT) was compared with low-dose CT coregistered to the same PET (rLD-CT) using the same metrics. PET accuracy was evaluated by calculating SUVs. Results: The robustness of the deep-learning coregistration framework was demonstrated in reduced PET counts and ULD-CT scenarios across tracers. All metrics indicated robust performance when comparing LC-rCT with rCT and rULD-CT with rLD-CT. Consistent SUVs across varying PET counts and ULD-CT conditions further validated the quantitative accuracy of the approach. Conclusion: This work highlights that neither the use of low-dose PET protocols nor ULD-CT compromise the performance of this coregistration framework across 4 tracers. For LAFOV PET, these findings support the feasibility of such a framework in imaging protocols with reduced radiation exposure.